These prognostic patterns of YY1 and CP2c expression in breast cancers were also observed in hepatocellular carcinoma (HCC) patients [28], but not in head and neck squamous cell carcinoma (HNSCC) patients [29]. This evidence concerns the gene YY1 and hepatocellular carcinoma.